499 related articles for article (PubMed ID: 14694107)
21. Expression of human papillomavirus type 6 L1 and L2 isolated in China and self assembly of virus-like particles by the products.
Wang M; Wang LL; Chen LF; Han YH; Zou YH; Si JY; Song GX
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jan; 35(1):27-34. PubMed ID: 12518224
[TBL] [Abstract][Full Text] [Related]
22. Generation and neutralization of pseudovirions of human papillomavirus type 33.
Unckell F; Streeck RE; Sapp M
J Virol; 1997 Apr; 71(4):2934-9. PubMed ID: 9060652
[TBL] [Abstract][Full Text] [Related]
23. Maturation of papillomavirus capsids.
Buck CB; Thompson CD; Pang YY; Lowy DR; Schiller JT
J Virol; 2005 Mar; 79(5):2839-46. PubMed ID: 15709003
[TBL] [Abstract][Full Text] [Related]
24. Production of Human papillomavirus pseudovirions in plants and their use in pseudovirion-based neutralisation assays in mammalian cells.
Lamprecht RL; Kennedy P; Huddy SM; Bethke S; Hendrikse M; Hitzeroth II; Rybicki EP
Sci Rep; 2016 Feb; 6():20431. PubMed ID: 26853456
[TBL] [Abstract][Full Text] [Related]
25. Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2.
Gambhira R; Jagu S; Karanam B; Gravitt PE; Culp TD; Christensen ND; Roden RB
J Virol; 2007 Nov; 81(21):11585-92. PubMed ID: 17715230
[TBL] [Abstract][Full Text] [Related]
26. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.
Varsani A; Williamson AL; de Villiers D; Becker I; Christensen ND; Rybicki EP
J Virol; 2003 Aug; 77(15):8386-93. PubMed ID: 12857908
[TBL] [Abstract][Full Text] [Related]
27. E1 protein of human papillomavirus type 1a is sufficient for initiation of viral DNA replication.
Gopalakrishnan V; Khan SA
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9597-601. PubMed ID: 7937813
[TBL] [Abstract][Full Text] [Related]
28. Expression of the bovine papillomavirus type 1, 2 and 4 L1 genes in the yeast Pichia pastoris.
Jesus AL; Mariz FC; Souza HM; Cordeiro MN; Coimbra EC; Leitão MC; Nascimento LM; Stocco RC; Beçak W; Freitas AC
Genet Mol Res; 2012 Aug; 11(3):2598-607. PubMed ID: 22869085
[TBL] [Abstract][Full Text] [Related]
29. The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains.
Day PM; Roden RB; Lowy DR; Schiller JT
J Virol; 1998 Jan; 72(1):142-50. PubMed ID: 9420209
[TBL] [Abstract][Full Text] [Related]
30. Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18.
Pastrana DV; Buck CB; Pang YY; Thompson CD; Castle PE; FitzGerald PC; Krüger Kjaer S; Lowy DR; Schiller JT
Virology; 2004 Apr; 321(2):205-16. PubMed ID: 15051381
[TBL] [Abstract][Full Text] [Related]
31. Sequences of bovine papillomavirus type 1 DNA--functional and evolutionary implications.
Ahola H; Stenlund A; Moreno-Lopez J; Pettersson U
Nucleic Acids Res; 1983 May; 11(9):2639-50. PubMed ID: 6304656
[TBL] [Abstract][Full Text] [Related]
32. Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins.
Hagensee ME; Yaegashi N; Galloway DA
J Virol; 1993 Jan; 67(1):315-22. PubMed ID: 8380079
[TBL] [Abstract][Full Text] [Related]
33. Interaction of tSNARE syntaxin 18 with the papillomavirus minor capsid protein mediates infection.
Bossis I; Roden RB; Gambhira R; Yang R; Tagaya M; Howley PM; Meneses PI
J Virol; 2005 Jun; 79(11):6723-31. PubMed ID: 15890910
[TBL] [Abstract][Full Text] [Related]
34. Interactions between papillomavirus L1 and L2 capsid proteins.
Finnen RL; Erickson KD; Chen XS; Garcea RL
J Virol; 2003 Apr; 77(8):4818-26. PubMed ID: 12663788
[TBL] [Abstract][Full Text] [Related]
35. Efficiency of delivery of DNA to cells by bovine papillomavirus type-1 L1/L2 pseudovirions.
Liu Y; Frazer IH; Liu WJ; Liu XS; McMillan N; Zhao KN
Appl Microbiol Biotechnol; 2001 Jul; 56(1-2):150-6. PubMed ID: 11499923
[TBL] [Abstract][Full Text] [Related]
36. [Construction and identification of non-replication recombinant vaccinia virus co-expressing human papillomavirus type 16 L1/L2/E6/E7 proteins].
Huang W; Tian HW; Ren J; Fan JT; Zhao L; Bian T; Lu ZH; Ruan L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):240-3. PubMed ID: 16261206
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression.
Hubert WG; Laimins LA
J Virol; 2002 Mar; 76(5):2263-73. PubMed ID: 11836404
[TBL] [Abstract][Full Text] [Related]
38. Chimeric papillomavirus-like particles.
Müller M; Zhou J; Reed TD; Rittmüller C; Burger A; Gabelsberger J; Braspenning J; Gissmann L
Virology; 1997 Jul; 234(1):93-111. PubMed ID: 9234950
[TBL] [Abstract][Full Text] [Related]
39. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
[TBL] [Abstract][Full Text] [Related]
40. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer.
Baek JO; Seo JW; Kwon O; Park SM; Kim CH; Kim IH
Enzyme Microb Technol; 2012 Mar; 50(3):173-80. PubMed ID: 22305172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
